Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for Esophageal Adenocarcinoma: Results from a large multicenter cohort

Gastroenterology

Volumn 145, Issue 3, 2013, Pages

  Gaddam, Srinivas ^a   Singh, Mandeep ^b,c   Balasubramanian, Gokulakrishnan ^c   Thota, Prashanthi ^c   Gupta, Neil ^a   Wani, Sachin ^d   Higbee, April D ^c   Mathur, Sharad C ^e   Horwhat, John D ^f   Rastogi, Amit ^b,c   Young, Patrick E ^f   Cash, Brooks D ^f   Bansal, Ajay ^b,c   Vargo, John J ^c   Falk, Gary W ^g   Lieberman, David A ^h   Sampliner, Richard E ⁱ   Sharma, Prateek ^b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF ARIZONA   (United States)

Author keywords

Barrett's Esophagus; Dysplasia; Esophageal Adenocarcinoma; Risk

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGOSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONDYSPLASTIC BARRETT ESOPHAGUS; PRIORITY JOURNAL;

EID: 84883170964     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.05.040     Document Type: Article

References (25)

1. P. Sharma Clinical practice. Barrett's esophagus N Engl J Med 361 2009 2548 2556
2. J. Lagergren, R. Bergstrom, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831
3. M.A. Eloubeidi, A.C. Mason, and R.A. Desmond Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98 2003 1627 1633
4. H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2005 142 146
5. S. Wani, G. Falk, and M. Hall Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma Clin Gastroenterol Hepatol 9 2011 220 227 quiz e26
6. American Gastroenterological Association American Gastroenterological Association medical position statement on the management of Barrett's esophagus Gastroenterology 140 2011 1084 1091
7. K.K. Wang, and R.E. Sampliner Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797
8. W.K. Hirota, M.J. Zuckerman, and D.G. Adler ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract Gastrointest Endosc 63 2006 570 580
9. R.J. Playford New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus Gut 55 2006 442
10. J. Boyer, R. Laugier, and M. Chemali French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett's esophagus Endoscopy 39 2007 840 842
11. F. Hvid-Jensen, L. Pedersen, and A.M. Drewes Incidence of adenocarcinoma among patients with Barrett's esophagus N Engl J Med 365 2011 1375 1383
12. M. Sikkema, P.J. de Jonge, and E.W. Steyerberg Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis Clin Gastroenterol Hepatol 8 2010 235 244 quiz e32
13. S. Bhat, H.G. Coleman, and F. Yousef Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study J Natl Cancer Inst 103 2011 1049 1057
14. S. Wani, G.W. Falk, and J. Post Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus Gastroenterology 141 2011 1179 1186 1186 e1
15. S.J. Spechler, P. Sharma, and R.F. Souza American Gastroenterological Association technical review on the management of Barrett's esophagus Gastroenterology 140 2011 e18 e52 quiz e13
16. R.E. Sampliner Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus Am J Gastroenterol 97 2002 1888 1895
17. R.H. Riddell, H. Goldman, and D.F. Ransohoff Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications Hum Pathol 14 1983 931 968
18. R.J. Schlemper, R.H. Riddell, and Y. Kato The Vienna classification of gastrointestinal epithelial neoplasia Gut 47 2000 251 255
19. E. Montgomery, M.P. Bronner, and J.R. Goldblum Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation Hum Pathol 32 2001 368 378
20. P.J. de Jonge, M. van Blankenstein, and C.W. Looman Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study Gut 59 2010 1030 1036
21. J.S. Wang, and M.I. Canto Predicting neoplastic progression in Barrett's esophagus Ann Gastroenterol Hepatol 1 2010 1 10
22. A. Bansal, I.H. Lee, and X. Hong Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study Am J Gastroenterol 106 2011 1055 1063
23. S. Gaddam, P.E. Young, and A. Wang Predicting high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in patients with non-dysplastic Barrett's esophagus (BE): results from a large, multicenter cohort study Gastroenterology 138 2010 S-333
24. S.J. Winawer, A.G. Zauber, and R.H. Fletcher Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society Gastroenterology 130 2006 1872 1885
25. D.A. Lieberman, D.K. Rex, and S.J. Winawer Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 143 2012 844 857